You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoma, Hepatocellular

Showing 1 - 25 of 9,618
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CT Imaging for Guiding PA-TACE for HCC

Recruiting
  • Carcinoma, Hepatocellular
  • postoperative adjuvant transarterial chemoembolization
  • Guangzhou, Guangdong, China
    ZhuJiang Hospital of Southern Medical University
Nov 30, 2023

Hepatocellular Carcinoma Trial in Yerevan

Recruiting
  • Hepatocellular Carcinoma
    • Yerevan, Armenia
      Nikomed Medical Center
    Jun 28, 2023

    Carcinoma, Hepatocellular Trial (Therasphere 90Y, Microwave Ablation)

    Not yet recruiting
    • Carcinoma, Hepatocellular
    • Therasphere 90Y
    • Microwave Ablation
    • (no location specified)
    Jul 12, 2023

    Process for Hepatocellular Carcinoma

    Not yet recruiting
    • Hepatocellular Carcinoma
      • (no location specified)
      May 5, 2023

      Resectable Hepatocellular Carcinoma Trial in Jakarta Pusat (Liver Resection)

      Completed
      • Resectable Hepatocellular Carcinoma
      • Liver Resection
      • Jakarta Pusat, DKI Jakarta, Indonesia
        Dr. Cipto Mangunkusumo General Hospital
      Aug 24, 2023

      Cirrhosis, Liver Trial (Epigallocatechin gallate (EGCG), Placebo)

      Not yet recruiting
      • Cirrhosis, Liver
      • Epigallocatechin gallate (EGCG)
      • Placebo
      • (no location specified)
      Aug 27, 2023

      Advanced Hepatocellular Carcinoma Trial (CD-801)

      Not yet recruiting
      • Advanced Hepatocellular Carcinoma
      • (no location specified)
      Oct 13, 2023

      Hepatocellular Carcinoma Trial in Mansoura (Sorafenib Tablets)

      Recruiting
      • Hepatocellular Carcinoma
      • Sorafenib Tablets
      • Mansoura, El-Dakahelia, Egypt
        Mansoura University Hospital
      Sep 3, 2023

      Unresectable Hepatocellular Carcinoma Trial in Nanjing (Yttrium-90 carbon microspheres SIRT)

      Recruiting
      • Unresectable Hepatocellular Carcinoma
      • Yttrium-90 carbon microspheres SIRT
      • Nanjing, China
        Gao-Jun Teng
      Jul 20, 2023

      Hepatocellular Carcinoma Trial in Seoul (Lenvatinib)

      Recruiting
      • Hepatocellular Carcinoma
      • Seoul, Korea, Republic of
        Asan Medical Center
      Nov 14, 2023

      Carcinoma, Hepatocellular, Hepatocellular Carcinoma, Hepatocellular Cancer Trial in Seoul (Microwave ablation)

      Active, not recruiting
      Has Results
      • Carcinoma, Hepatocellular
      • +3 more
      • Microwave ablation
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Jan 23, 2023

      Hepatocellular Carcinoma Trial in Wuhan (Sintilimab, Transarterial Chemoembolization (TACE))

      Not yet recruiting
      • Hepatocellular Carcinoma
      • Sintilimab
      • Transarterial Chemoembolization (TACE)
      • Wuhan, Hubei, China
        Tongji Hospital, Tongji Medical College, Huazhong University of
      Oct 17, 2023

      Carcinoma, Hepatocellular Trial (Atezolizumab, Bevacizumab, Tiragolumab)

      Not yet recruiting
      • Carcinoma, Hepatocellular
      • (no location specified)
      Jun 14, 2023

      Hepatocellular Carcinoma Trial in Guangzhou (Lenvatinib, Tislelizumab Combined with RALOX Regimen HAIC)

      Recruiting
      • Hepatocellular Carcinoma
      • Lenvatinib, Tislelizumab Combined with RALOX Regimen HAIC
      • Guangzhou, Guangdong, China
        Guangdong Provincial People's Hospital
      Jul 12, 2023

      Hepatocellular Carcinoma Trial in Jakarta Pusat (Autologous Natural Killer Cell Therapy, Clinimacs Plus)

      Recruiting
      • Hepatocellular Carcinoma
      • Autologous Natural Killer Cell Therapy
      • Clinimacs Plus
      • Jakarta Pusat, Jakarta, Indonesia
        Cipto Mangunkusumo General Hospital
      Sep 24, 2023

      Hepatocellular Carcinoma Trial in Hangzhou (Fruquintinib, Sintilimab, Transcatheter arterial chemoembolization(TACE))

      Recruiting
      • Hepatocellular Carcinoma
      • Hangzhou, Zhejiang, China
        Guoliang Shao
      Aug 1, 2023

      Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable, Liver Cancer Trial (EYE90 Microspheres Treatment)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • +2 more
      • EYE90 Microspheres Treatment
      • (no location specified)
      Jul 12, 2023

      Hepatocellular Carcinoma Trial in Guangzhou (SIRT)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • SIRT
      • Guangzhou, Guangdong, China
        The Second Affiliated Hospital of Guangzhou Medical University
      Aug 9, 2023

      Hepatocellular Carcinoma Trial in Villejuif (RAPID procedure)

      Not yet recruiting
      • Hepatocellular Carcinoma
      • RAPID procedure
      • Villejuif, France
        AP-HP, Paul Brousse Hospital
      Jul 24, 2023

      Hepatocellular Carcinoma Trial in Shanghai (M-TACE)

      Enrolling by invitation
      • Hepatocellular Carcinoma
      • M-TACE
      • Shanghai, Shanghai, China
        Department of Interventional Radiology, Zhongshan Hospital, Fuda
      May 24, 2023

      Hepatocellular Carcinoma, Liver Cancer Trial in Seoul (IDA-TACE, DOX-TACE)

      Recruiting
      • Hepatocellular Carcinoma
      • Liver Cancer
      • IDA-TACE
      • DOX-TACE
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Oct 27, 2023

      Deep Learning Image Reconstruction for Abdominal CT of

      Recruiting
      • Hepatocellular Carcinoma
        • Nancy, France
          CHRU de Nancy
        Sep 13, 2023

        Hepatocellular Carcinoma Trial in Seoul (Microwave ablation)

        Recruiting
        • Hepatocellular Carcinoma
        • Microwave ablation
        • Seoul, Korea, Republic of
          Seoul National University Hospital
        Oct 10, 2023

        Hepatocellular Carcinoma Trial in Shanghai ([68Ga]Ga-NOTA-RG2 PET Imaging)

        Recruiting
        • Hepatocellular Carcinoma
        • [68Ga]Ga-NOTA-RG2 PET Imaging
        • Shanghai, China
          Huashan Hospital
        Nov 19, 2023

        Hepatocellular Carcinoma Trial (Atezolizumab, Bevacizumab)

        Not yet recruiting
        • Hepatocellular Carcinoma
        • (no location specified)
        Oct 18, 2023